Bitzegeio et al., 2010 - Google Patents

Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors

Bitzegeio et al., 2010

View HTML
Document ID
15537962382771624090
Author
Bitzegeio J
Bankwitz D
Hueging K
Haid S
Brohm C
Zeisel M
Herrmann E
Iken M
Ott M
Baumert T
Pietschmann T
Publication year
Publication venue
PLoS pathogens

External Links

Snippet

Hepatitis C virus (HCV) naturally infects only humans and chimpanzees. The determinants responsible for this narrow species tropism are not well defined. Virus cell entry involves human scavenger receptor class B type I (SR-BI), CD81, claudin-1 and occludin. Among …
Continue reading at journals.plos.org (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Similar Documents

Publication Publication Date Title
Bitzegeio et al. Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors
Catanese et al. Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants
Bankwitz et al. Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes
Syder et al. Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors
Fafi-Kremer et al. Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation
Sourisseau et al. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies
Witteveldt et al. CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells
Keck et al. Non-random escape pathways from a broadly neutralizing human monoclonal antibody map to a highly conserved region on the hepatitis C virus E2 glycoprotein encompassing amino acids 412–423
Dorner et al. Completion of the entire hepatitis C virus life cycle in genetically humanized mice
Blanchard et al. Hepatitis C virus entry depends on clathrin-mediated endocytosis
Meunier et al. Apolipoprotein c1 association with hepatitis C virus
Grove et al. Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity
Koutsoudakis et al. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses
Morin et al. Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees
Tong et al. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection
Bertaux et al. Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry
Bankwitz et al. Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity
Hopcraft et al. Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins
Fofana et al. A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission
Prentoe et al. Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus
Ciesek et al. Impact of intra-and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles
Bankwitz et al. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins
Dhillon et al. Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies
McCaffrey et al. The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity
Wu et al. Cell death-inducing DFFA-like effector b is required for hepatitis C virus entry into hepatocytes